Ian Dunn to Biomarkers, Tumor
This is a "connection" page, showing publications Ian Dunn has written about Biomarkers, Tumor.
Connection Strength
1.113
-
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors. Oncotarget. 2016 Nov 22; 7(47):76565-76576.
Score: 0.435
-
Chordoma: Genetics and Contemporary Management. Int J Mol Sci. 2024 May 28; 25(11).
Score: 0.183
-
Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Sci Rep. 2021 09 09; 11(1):18009.
Score: 0.152
-
Immunophenotype of Vestibular Schwannomas. Otol Neurotol. 2020 12; 41(10):e1290-e1296.
Score: 0.144
-
Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5. Oncotarget. 2014 Nov 15; 5(21):10596-606.
Score: 0.095
-
Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas. Oncotarget. 2014 Sep 30; 5(18):8083-92.
Score: 0.094
-
HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder. Br J Cancer. 2003 Oct 06; 89(7):1305-9.
Score: 0.011